All research
MGF 2025-07-01 ClinicalTrials

Serum IGF-1 Dynamic Changes Post-Intracerebral Hemorrhage Explored for Prognostic Correlation

Study on Dynamic Changes of Serum IGF-1 Post-Cerebral Hemorrhage and Its Prognostic Correlation

Background

Intracerebral hemorrhage (ICH) is a devastating form of stroke characterized by bleeding within the brain parenchyma, leading to high rates of morbidity and mortality. Current prognostic indicators for ICH severity and patient outcomes are often limited, making it challenging to precisely stratify risk and optimize treatment timing. Insulin-like Growth Factor-1 (IGF-1) is a pleiotropic peptide hormone known for its neuroprotective and neurotrophic properties, playing roles in cell survival, proliferation, and angiogenesis. Its involvement in brain injury and repair mechanisms suggests that dynamic changes in serum IGF-1 levels could serve as a valuable biomarker for assessing ICH progression and predicting patient prognosis, potentially guiding more timely and targeted clinical interventions.

Study Design

This study aimed to dynamically observe serum IGF-1 levels in intracerebral hemorrhage patients. The researchers' objective was to explore the impact and correlation of these IGF-1 changes with the severity of the patient's condition and their subsequent prognosis. The study design involved serial measurements of serum IGF-1 over time, although specific details regarding the patient cohort, sample size, measurement frequency, or the exact methodology (e.g., radioimmunoassay, ELISA) were not provided in the abstract. The primary endpoint was to establish a reference for clinical treatment timing based on these observed correlations.

Results

The abstract for this study primarily outlines its purpose and objectives rather than presenting specific findings or quantitative results. It states the aim was to dynamically observe changes in serum IGF-1 levels following intracerebral hemorrhage and to explore their correlation with patient condition severity and prognosis. However, no data, statistical analyses, p-values, percentages, or specific correlations (e.g., positive, negative, or temporal patterns) were reported within the abstract itself. Therefore, no concrete findings or numerical outcomes can be extracted or quoted from the provided text.

Why It Matters

While the abstract does not present specific findings, the aim of this research highlights the critical need for improved prognostic biomarkers in intracerebral hemorrhage (ICH). If future full publications from this study or similar research demonstrate a clear, quantifiable correlation between dynamic serum IGF-1 levels and ICH severity or patient prognosis, it could significantly impact clinical practice. Such a correlation could establish IGF-1 as a valuable, non-invasive biomarker, enabling earlier and more precise risk stratification for ICH patients. This could lead to more informed decisions regarding the intensity of care, rehabilitation planning, and the timing of potential neuroprotective or surgical interventions. For biohackers and clinicians, understanding these dynamic changes could eventually inform novel therapeutic strategies or monitoring protocols, though much more research, including specific data and validation, is required before any practical application.


intracerebral-hemorrhage ich igf-1 biomarker prognosis neurological
Source: clinicaltrials:NCT07043504 · Ingested 2026-06-09 · Digest: gemini-2.5-flash